AI-driven drug discovery company Insilico Medicine raised approximately HKD 2.28 billion (more than US$290 million) in its initial public offering on the Hong Kong Stock Exchange today, marking the largest biotech IPO in the city this year.
#advertisement
Trading under the stock code 03696.HK, Insilico became the first company focused on AI-powered drug discovery to go public on the Main Board under Chapter 8.05…
